All posts tagged
The Most Important Battle in Gene Editing: CRISPR versus TALEN
What are the Best Countries to Recruit Biotech Talents in 2017?
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
10 Hot European Biotechs to Observe in 2017 🚀
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
The 8 Biggest Biotech Medical Fails of 2016 in Europe
UPDATE: No Clear Winner in the CRISPR Patent Battle
How much of a Gamble is Investing in CRISPR?
CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?
€350M CRISPR Joint Venture now has a Name and an Office
CRISPR Therapeutics increases its Series B to a Massive €125M
CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy
Labiotech UG, All Rights Reserved -
Send this to a friend